IHH and familial pancreatic carcinoma: Aspc-1, Capan-1, Panc-1 and T3M4 pancreatic cancer cells were treated with recombinant TGF-β1, BMP2, FGF2, Shh, Ihh and TNF-α for 48 h as described previously [17].